Bernegger S, Jarzab M, Wessler S, Posselt G. Proteolytic landscapes in gastric pathology and cancerogenesis. Int J Mol Sci, 2022, 23: 2419.     

Jarzab M, Posselt G, Meisner-Kober N, Wessler S. Helicobacter pylori-derived outer membrane vesicles (OMVs): role in bacterial pathogenesis? Microorganisms, 2020, 8: 1328.

Bernegger S, Brunner C, Vizovišek M, Fonovic M, Jarzab M, Cuciniello G, Giordano F, Stanojlovic V, Simister P, Feller SM, Obermeyer G, Posselt G, Turk B, Cabrele C, Schneider G, Wessler S. A novel FRET peptide assay reveals efficient Helicobacter pylori HtrA inhibition through zinc and copper binding. Sci Rep, 2020, 10: 10563.

Abfalter CM, Bernegger S, Jarzab M, Posselt G, Ponnuraj K, Wessler S. The proteolytic activity of Listeria monocytogenes HtrA. BMC Microbiol, 2019, 19: 255.

Wenta T, Rychlowski M, Jarzab M, Lipinska B. HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death. Cells, 2019, 8i: E1112.

Wenta T, Jarzab M, Rychlowski M, Borysiak M, Latala A, Zurawa-Janicka D, Filipek A, Lipinska B. Cellular substrates and pro-apoptotic function of the human HtrA4 protease. J Proteomics, 2019, 209:103505.

Wenta T, Rychlowski M, Jurewicz E, Jarzab M, Zurawa-Janicka D, Filipek A, Lipinska B. The HtrA3 protease promotes drug-induced death of lung cancer cells by cleavage of the X-linked inhibitor of apoptosis protein (XIAP). FEBS J, 2019, in press.

Wenta T, Zurawa-Janicka D, Rychlowski M, Jarzab M, Glaza P, Lipinska A, Bienkowska-Szewczyk K, Herman-Antosiewicz A, Skorko-Glonek J, Lipinska B. HtrA3 is a cellular partner of cytoskeleton proteins and TCP1a chaperonin. J Proteomics, 2018, 177: 88-111.

Wysocka M, Sychowska K, Gruba N, Winiarski L, Skorenski M, Psurski M, Makowska J, Gieldon A, Wenta T, Jarzab M, Glaza P, Zdancewicz J, Sienczyk M, Lipinska B, Lesner A. Selection of Effective HTRA3 Activators Using Combinatorial Chemistry. ACS Comb Sci, 2017, 19: 565-573.

Wenta T, Glaza P, Jarzab M, Zarzecka U, Zurawa-Janicka D, Lesner A, Skórko-Glonek J, Lipinska B. The role of the LB structural loop and its interactions with the PDZ domain of the human HtrA3 protease. Biochim Biophys Acta, 2017, 1865: 1141-1151.

Zurawa-Janicka D, Wenta T, Jarzab M, Skorko-Glonek J, Glaza P, Gieldon A, Ciarkowski J, Lipinska B. Structural insights into the activation mechanisms of human HtrA serine proteases. Arch Biochem Biophys, 2017, 621: 6-23.

Gieldon A, Zurawa-Janicka D, Jarzab M, Wenta T, Golik P, Dubin G, Lipinska B, Ciarkowski J. Distinct 3D Architecture and Dynamics of the Human HtrA2(Omi) Protease and Its Mutated Variants. PLoS One, 2016, 11: e0161526.

Jarzab M, Wenta T, Zurawa-Janicka D, Polit A, Gieldon AJ, Wysocka M, Glaza P, Skorko-Glonek J, Ciarkowski J, Lesner A, Lipinska B. Intra- and intersubunit changes accompanying thermal activation of the HtrA2(Omi) protease homotrimer. Biochim Biophys Acta, 2016, 1864: 283-296.

Glaza P, Osipiuk J, Wenta T, Zurawa-Janicka D, Jarzab M, Lesner A, Banecki B, Skorko-Glonek J, Joachimiak A, Lipinska B. Structural and Functional Analysis of Human HtrA3 Protease and Its Subdomains. PLoS One, 2015, 10: e0131142.

Wysocka M, Wojtysiak A, Okonska M, Gruba N, Jarzab M, Wenta T, Lipinska B, Grzywa R, Sienczyk M, Rolka K, Lesner A. Design and synthesis of new substrates of HtrA2 protease. Anal Biochem, 2015, 475: 44-52.

Skórko-Glonek J, Żurawa-Janicka D, Koper T, Jarzab M, Figaj D, Glaza P, Lipinska B.  HtrA protease family as therapeutic targets. Current Pharmaceutical Design, 2013, 19: 977-1009.

Żurawa-Janicka D, Jarząb M, Polit A, Skórko-Glonek J, Lesner A, Gitlin A, Gieldon A, Ciarkowski J, Glaza P, Lubomska A, Lipińska B. Temperature-induced changes of HtrA2(Omi) protease activity and structure. Cell Stress and Chaperones, 2013, 18: 35-51.

Jarzab M, Zurawa-Janicka D, Lipinska B. HTRA2 (HtrA serine peptidase 2). Atlas Genet Cytogenet Oncol Haematol, December 2011.

Klasa-Mazurkiewicz D, Jarząb M, Milczek T, Lipińska B, Emerich J. Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients. Pol J Pathol, 2011,62: 31-40.